Hypersensitivity Pneumonitis and Pulmonary Vasculitis with Eosinophilia in a Patient Taking an L-Tryptophan Preparation

  1. William D. Travis, MD;
  2. Michael E. Kalafer, MD;
  3. Howard S. Robin, MD; and
  4. F. J. Luibel, MD
    • Current Author Addresses: Dr. Travis: Laboratory of Pathology, Building 10, Room 2N212, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

      Dr. Kalafer: San Diego Pulmonary and Critical Care Medical Group, Sharp Cabrillo Hospital, 3475 Kenyon Street, San Diego, CA 92110.

      Drs. Robin and Luibel: Department of Pathology, Sharp Cabrillo Hospital, 3475 Kenyon Street, San Diego, CA 92110.

    Excerpt

    Dietary intake of L-tryptophan tablets has recently been found to be associated with a potentially fatal disorder called the eosinophilia-myalgia syndrome (1, 2). This disorder is primarily characterized by peripheral blood eosinophilia and severe myalgias. We report a case of hypersensitivity pneumonitis and pulmonary vasculitis associated with eosinophilia in a patient taking an L-tryptophan preparation.

    Case Report A 70-year-old woman presented with a 1- to 2-week history of fatigue and weakness, cough with brown sputum, and several days of progressive dyspnea associated with bifrontal headache. An outpatient chest radiograph, 2 days before admission, showed bilateral perihilar and lower-lobe alveolar infiltrates,

    This 100-word excerpt has been provided in the absence of an abstract.

    Article and Author Information

    • From the National Institutes of Health, Bethesda, Maryland; and Sharp Cabrillo Hospital, San Diego, California. For current author addresses, see end of text.

    • Requests for Reprints: William D. Travis, MD, Laboratory of Pathology, Building 10, Room 2N212, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

    « Previous | Next Article »Table of Contents